The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis
- PMID: 21892620
- DOI: 10.1007/s12031-011-9627-y
The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis
Abstract
Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD) is a progressive, fatal genetic disorder with variable penetrance, predominantly affecting three main tissue types: muscle (IBM), bone (PDB), and brain (FTD). IBMPFD is caused by mutations in the ubiquitously expressed valosin-containing protein (VCP) gene, a member of the AAA-ATPase superfamily. The majority of individuals who develop IBM have progressive proximal muscle weakness. Muscle biopsies reveal rimmed vacuoles and inclusions that are ubiquitin- and TAR DNA binding protein-43 (TDP-43)-positive using immunohistochemistry. PDB, seen in half the individuals, is caused by overactive osteoclasts and is associated clinically with pain, elevated serum alkaline phosphatase, and X-ray findings of coarse trabeculation and sclerotic lesions. FTD diagnosed at a mean age of 55 years in a third of individuals is characterized clinically by comprehension deficits, dysnomia, dyscalculia, and social unawareness. Ubiquitin- and TDP-43-positive neuronal inclusions are also found in the brain. Genotype-phenotype correlations are difficult with marked intra-familial and inter-familial variations being seen. Varied phenotypes within families include frontotemporal dementia, amyotrophic lateral sclerosis, Parkinsonism, myotonia, cataracts, and anal incompetence, among others. Cellular and animal models indicate pathogenetic disturbances in IBMPFD tissues including altered protein degradation, autophagy pathway alterations, apoptosis, and mitochondrial dysfunction. Currently, mouse and drosophila models carrying VCP mutations provide insights into the human IBMPFD pathology and are useful as tools for preclinical studies and testing of therapeutic strategies. In this review, we will explore the pathogenesis and clinical phenotype of IBMPFD caused by VCP mutations.
Similar articles
-
Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.Neuromuscul Disord. 2009 May;19(5):308-15. doi: 10.1016/j.nmd.2009.01.009. Epub 2009 Apr 19. Neuromuscul Disord. 2009. PMID: 19380227 Free PMC article. Review.
-
The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.PLoS One. 2012;7(9):e46308. doi: 10.1371/journal.pone.0046308. Epub 2012 Sep 28. PLoS One. 2012. PMID: 23029473 Free PMC article.
-
Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.Hum Mol Genet. 2010 May 1;19(9):1741-55. doi: 10.1093/hmg/ddq050. Epub 2010 Feb 10. Hum Mol Genet. 2010. PMID: 20147319
-
Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.J Cell Biol. 2009 Dec 14;187(6):875-88. doi: 10.1083/jcb.200908115. J Cell Biol. 2009. PMID: 20008565 Free PMC article.
-
Valosin-containing protein and the pathogenesis of frontotemporal dementia associated with inclusion body myopathy.Acta Neuropathol. 2007 Jul;114(1):55-61. doi: 10.1007/s00401-007-0224-7. Epub 2007 Apr 25. Acta Neuropathol. 2007. PMID: 17457594 Review.
Cited by
-
Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease.Hum Mol Genet. 2014 Mar 1;23(5):1333-44. doi: 10.1093/hmg/ddt523. Epub 2013 Oct 24. Hum Mol Genet. 2014. PMID: 24158850 Free PMC article.
-
Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.Neurobiol Aging. 2014 Jun;35(6):1491-8. doi: 10.1016/j.neurobiolaging.2013.12.029. Epub 2013 Dec 30. Neurobiol Aging. 2014. PMID: 24462217 Free PMC article.
-
Altered intersubunit communication is the molecular basis for functional defects of pathogenic p97 mutants.J Biol Chem. 2013 Dec 20;288(51):36624-35. doi: 10.1074/jbc.M113.488924. Epub 2013 Nov 6. J Biol Chem. 2013. PMID: 24196964 Free PMC article.
-
Involvement of peripheral and central nervous systems in a valosin-containing protein mutation.J Clin Neurol. 2014 Apr;10(2):166-70. doi: 10.3988/jcn.2014.10.2.166. Epub 2014 Apr 23. J Clin Neurol. 2014. PMID: 24829604 Free PMC article.
-
Frontotemporal dementia.Lancet. 2015 Oct 24;386(10004):1672-82. doi: 10.1016/S0140-6736(15)00461-4. Lancet. 2015. PMID: 26595641 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous